Anankastic personality disorder

F5_ANAPER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F60.5 Hospital discharge: ICD-8 — 3014 Cause of death: ICD-10 — F60.5 Cause of death: ICD-8 — 3014 2 out of 7 registries used, show all original rules.	1505
4. Check minimum number of events None	1505
5. Include endpoints None	1505
6. Filter based on genotype QC (FinnGen only)	1505

Control definitions (FinnGen only)

Control exclude: F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F60
Name in latin: Personalitas anancastica

NAME	F5_ANAPER
CONTROL_EXCLUDE	F5_PERSOBEH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F605
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	3014
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F605
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	3014
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anankastic personality disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9112	5724	3364
Only index persons	8865	5645	3220
Unadjusted period prevalence (%)
Whole population	0.14	0.16	0.09
Only index persons	0.18	0.21	0.12
Median age at first event (years)
Whole population	42.79	41.46	45.09
Only index persons	42.65	41.30	45.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1505	1060	445
Unadjusted period prevalence (%)	0.31	0.36	0.20
Median age at first event (years)	43.43	42.01	46.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1359: Matched controls
13588

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

29.9

323.0

490

251

F60.5

ICD-10 Finland

Anankastic personality disorder

4503599627370496.0

323.0

1342

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

20.5

323.0

544

429

N05AH04

ATC

quetiapine; oral

11.0

306.2

708

1220

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

20.5

290.4

458

329

N06AX16

ATC

venlafaxine; oral

10.6

284.5

661

1116

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

11.6

239.5

498

646

N06AX11

ATC

mirtazapine; oral

6.7

224.8

843

2675

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.3

208.1

545

1017

N06AB10

ATC

escitalopram; oral

5.7

174.7

660

1923

N06AX12

ATC

bupropion; oral

10.4

163.7

348

434

N06AB06

ATC

sertraline; oral

7.5

162.7

443

828

N05BA04

ATC

oxazepam; oral

5.1

149.7

623

1939

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.4

148.0

399

722

N06AB04

ATC

citalopram; systemic

5.2

145.5

574

1673

F61.0

ICD-10 Finland

Mixed personality disorders

392.0

143.8

142

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

305.1

137.0

137

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.3

136.9

290

350

N06AX21

ATC

duloxetine; oral

6.7

136.9

397

786

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

12.0

135.6

262

264

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1349.9

128.3

123

N06AB03

ATC

fluoxetine; oral

6.2

126.7

394

844

N03AX09

ATC

lamotrigine; oral

10.3

123.0

259

305

F34.1

ICD-10 Finland

Dysthymia

12.6

119.2

224

210

P76

ICPC

Depressive disorder

7.7

114.6

290

461

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

17.1

113.8

186

125

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

8.2

113.4

274

405

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.0

112.0

349

736

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

18.0

111.1

178

113

F60.9

ICD-10 Finland

Personality disorder, unspecified

1100.4

105.8

102

N06AX26

ATC

vortioxetine; oral

7.8

103.0

257

395

N05AH03

ATC

olanzapine; systemic

8.3

97.6

232

329

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

11.9

94.0

180

172

N05CF01

ATC

zopiclone; oral

3.5

91.7

570

2301

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

16.0

91.6

153

107

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.3

91.2

312

718

N05AX08

ATC

risperidone; systemic

8.2

90.4

216

307

N05BA01

ATC

diazepam; systemic, rectal

4.8

82.4

311

789

N05AX12

ATC

aripiprazole; systemic

9.2

81.1

178

218

P03

ICPC

Feeling depressed

4.6

78.3

312

832

F60.8

ICD-10 Finland

Other specific personality disorders

802.6

78.1

ZY010

NOMESCO Finland

Hospital outpatient

7.3

78.0

200

313

F31.8

ICD-10 Finland

Other bipolar affective disorders

16.5

78.0

128

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

268.1

75.2

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

12.5

74.9

139

123

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

15.7

74.7

125

N06AB05

ATC

paroxetine; oral

5.8

71.8

222

444

N03AG01

ATC

valproic acid; systemic, rectal

6.5

70.1

195

340

N05CF02

ATC

zolpidem; oral

3.5

68.9

396

1439

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

15.0

67.6

115

F40.1

ICD-10 Finland

Social phobias

12.9

66.5

121

102

P01

ICPC

Feeling anxious/nervous/tense

3.8

63.2

305

953

N06AG02

ATC

moclobemide; oral

7.9

62.7

150

209

SPAT1240

SPAT

Therapeutic discussion

3.7

61.0

306

985

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

6.9

60.9

160

256

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

8.0

60.7

144

198

N03AX16

ATC

pregabalin; oral

3.1

60.5

426

1766

Z2445

NOMESCO Finland

Psychologist

7.0

58.3

152

240

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

15.2

58.1

N05BA12

ATC

alprazolam; oral

4.3

58.0

241

653

N06AX03

ATC

mianserin; oral

7.5

57.4

142

208

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.9

56.8

150

241

N06AA09

ATC

amitriptyline; systemic

4.6

54.8

207

509

N06AX22

ATC

agomelatine; oral

9.4

54.4

116

133

N05CD07

ATC

temazepam; oral

4.6

53.5

201

491

C07AA05

ATC

propranolol; systemic

2.8

51.3

400

1742

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

15.3

50.7

N05AN01

ATC

lithium; oral

10.1

50.0

102

108

F32.1

ICD-10 Finland

Moderate depressive episode

4.6

49.9

187

454

N05BE01

ATC

buspirone; oral

8.6

49.9

112

140

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

19.5

48.4

N06AX05

ATC

trazodone; oral

9.3

48.1

103

119

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

8.3

48.1

110

142

N03AE01

ATC

clonazepam; systemic

5.5

48.0

150

298

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.9

46.3

163

370

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

7.1

45.9

117

178

N05AA02

ATC

levomepromazine; systemic

7.5

45.7

112

161

P29

ICPC

Psychological sympt/compl other

4.5

44.8

170

416

P99

ICPC

Psychological disorders other

7.4

43.4

107

155

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.8

43.1

201

595

N06AB08

ATC

fluvoxamine; oral

9.2

43.0

106

F41.00

ICD-10 Finland

Moderate panic disorder

10.1

42.4

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

8.4

42.3

122

ZYC01

NOMESCO Finland

Remote contact by phone

5.7

42.1

128

245

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

10.2

42.1

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

11.1

41.9

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

35.1

41.9

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

216.5

41.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.5

41.1

111

183

F99

ICD-10 Finland

Mental disorder, not otherwise specified

9.3

40.9

F60.0

ICD-10 Finland

Paranoid personality disorder

+∞

40.8

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

7.9

40.4

128

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.0

39.6

114

204

N03AX12

ATC

gabapentin; oral

2.9

39.4

269

1052

F90.0

ICD-10 Finland

Disturbance of activity and attention

6.9

39.2

101

156

N06AX18

ATC

reboxetine; oral

18.2

39.1

F39

ICD-10 Finland

Unspecified mood [affective] disorder

10.4

39.1

IGY02

NOMESCO Finland

Psychiatric monitoring contact

8.4

39.0

111

N05AB03

ATC

perphenazine; systemic, rectal

7.1

38.8

147

N06AA12

ATC

doxepin; systemic

5.5

38.4

119

233

AA400

NOMESCO Finland

Electroconvulsive therapy

17.4

37.9

Z2446

NOMESCO Finland

Social worker

4.4

37.0

143

355

N06BA04

ATC

methylphenidate; oral

7.4

36.7

129

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.9

36.7

164

465

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

10.2

36.3

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

9.0

36.2

F43.1

ICD-10 Finland

Post-traumatic stress disorder

6.4

35.5

162

IGY99

NOMESCO Finland

Other psychiatric treatment contact

9.1

35.4

F60.7

ICD-10 Finland

Dependent personality disorder

356.0

35.1

SPAT1307

SPAT

Psychosocial counselling and guidance

3.5

33.9

170

530

P74

ICPC

Anxiety disorder/anxiety state

4.9

33.7

115

251

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

33.2

563

3461

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.3

33.1

129

322

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

33.1

343

1687

G47.3

ICD-10 Finland

Sleep apnoea

2.4

32.7

334

1629

F32

ICD-10 Finland

Depressive episode

4.0

32.1

137

372

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.4

32.0

123

303

R06.0

ICD-10 Finland

Dyspnoea

2.4

31.7

328

1606

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

15.4

31.5

N05AF03

ATC

chlorprothixene; systemic

7.5

31.1

105

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

12.1

30.6

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

30.5

258

1133

M79.7

ICD-10 Finland

Fibromyalgia

4.8

30.1

105

234

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

11.0

29.7

R53

ICD-10 Finland

Malaise and fatigue

2.3

28.4

305

1512

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.8

28.3

217

A02BC02

ATC

pantoprazole; systemic

1.9

28.1

843

6278

N06AX17

ATC

milnacipran; oral

13.8

27.9

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

27.6

318

1626

P06

ICPC

Sleep disturbance

2.8

27.5

190

737

H03AA01

ATC

levothyroxine sodium; systemic

2.2

27.4

353

1900

N07BB01

ATC

disulfiram; oral

4.6

27.1

227

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.9

26.8

116

318

F32.8

ICD-10 Finland

Other depressive episodes

8.7

26.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

26.6

131

401

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

10.0

26.4

SPAT1301

SPAT

No procedures

2.0

26.3

424

2496

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

16.0

26.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

7.0

25.6

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

13.7

25.6

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

9.0

25.4

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.8

25.3

131

N05BA06

ATC

lorazepam; systemic, sublingual

5.0

25.3

178

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.0

25.1

104

275

L03

ICPC

Low back symptom/complaint

2.1

24.5

356

2002

R51.80

ICD-10 Finland

Headache

2.3

24.3

268

1333

P80

ICPC

Personality disorder

29.7

24.1

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.0

24.0

N02AX02

ATC

tramadol; systemic, rectal

1.9

24.0

533

3506

F31

ICD-10 Finland

Bipolar affective disorder

9.2

23.9

F33.8

ICD-10 Finland

Other recurrent depressive disorders

12.3

23.9

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.5

23.8

211

942

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

23.7

437

2688

SPAT1310

SPAT

Counselling related to known health issue

1.9

23.6

447

2776

M54.5

ICD-10 Finland

Low back pain

1.9

23.5

489

3136

F45.0

ICD-10 Finland

Somatization disorder

19.9

23.5

Z3231

NOMESCO Finland

Registered nurse

2.0

23.3

358

2052

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

23.0

321

1767

C07AB07

ATC

bisoprolol; oral

1.9

22.8

461

2918

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

22.7

153

582

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

17.9

22.7

N06AA04

ATC

clomipramine; systemic

8.1

22.6

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

22.4

784

5925

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

22.3

360

2100

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.9

22.2

158

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

10.3

21.9

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

7.9

21.9

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

9.5

21.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

21.9

109

336

A04

ICPC

Weakness/tiredness general

2.5

21.9

190

835

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

14.1

21.9

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

18.8

21.8

F60.1

ICD-10 Finland

Schizoid personality disorder

223.4

21.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

21.5

354

2071

A02BC05

ATC

esomeprazole; systemic

1.8

21.4

536

3632

F33

ICD-10 Finland

Recurrent depressive disorder

5.6

21.3

117

A02BA02

ATC

ranitidine; systemic

2.2

21.2

244

1231

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

21.2

148

575

A02BC03

ATC

lansoprazole; oral

1.9

21.2

377

2271

IBA03

NOMESCO Finland

Psychotherapy evaluation

10.0

21.2

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

12.2

21.1

R02

ICPC

Shortness of breath/dyspnoea

2.6

21.0

165

685

F61

ICD-10 Finland

Mixed and other personality disorders

61.0

20.9

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

19.8

20.9

N03AX11

ATC

topiramate; oral

4.6

20.9

164

F10.20

ICD-10 Finland

Alcohol dependence currently independent

7.1

20.8

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

20.6

252

1304

N05AF01

ATC

flupentixol; systemic

7.8

20.4

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

11.9

20.3

Z73.0

ICD-10 Finland

Burn-out

4.0

20.3

222

R03AC02

ATC

salbutamol; inhalant

1.7

20.3

736

5550

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

16.3

20.2

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

20.0

1021

8512

S18

ICPC

Laceration/cut

1.8

19.9

491

3286

A01

ICPC

Pain general/multiple sites

3.0

19.8

123

443

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.2

19.6

189

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.9

19.5

215

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

19.5

582

4124

A06AD11

ATC

lactulose; oral

2.6

19.4

147

599

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.3

19.4

100

317

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

11.2

19.2

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

19.2

133

514

M79.6

ICD-10 Finland

Pain in limb

1.8

19.2

470

3133

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

19.2

703

5280

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.2

19.1

103

337

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.8

19.1

229

R06.5

ICD-10 Finland

Mouth breathing

2.6

18.9

143

581

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

18.8

K07.60

ICD-10 Finland

Snapping jaw

3.0

18.8

111

385

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

18.7

221

1123

N02BE01

ATC

paracetamol; systemic, rectal

1.9

18.6

1125

9762

SPAT1260

SPAT

Consultation of another employee

2.1

18.4

241

1281

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

18.2

268

1492

L17

ICPC

Foot/toe symptom/complaint

1.9

18.0

313

1855

AA1AD

NOMESCO Finland

CT of head and brain

2.0

18.0

254

1389

SPAT1243

SPAT

Psychiatric/psychological examination

4.1

17.9

181

F50.9

ICD-10 Finland

Eating disorder, unspecified

9.0

17.7

SPAT1241

SPAT

Extensive assessment of psychosocial situation

6.9

17.6

SPAT1263

SPAT

Sampling

1.7

17.5

578

4175

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

17.5

938

7738

S29

ICPC

Skin symptom/complaint other

2.1

17.5

216

1116

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

17.3

304

F50.1

ICD-10 Finland

Atypical anorexia nervosa

11.3

17.3

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.5

17.1

142

607

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

17.0

111

412

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

17.0

104

372

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.3

17.0

151

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

16.9

133

553

N06AA06

ATC

trimipramine; systemic

5.1

16.8

107

N05AL01

ATC

sulpiride; systemic

7.5

16.8

F60.2

ICD-10 Finland

Dissocial personality disorder

+∞

16.7

R96

ICPC

Asthma

2.6

16.7

131

544

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.2

16.6

296

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

16.6

185

912

SPAT1284

SPAT

Extensive health certificate

4.1

16.5

165

L28

ICPC

Limited function/disability (L)

2.3

16.5

161

747

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

11.3

16.3

D01

ICPC

Abdominal pain/cramps general

2.2

16.3

170

817

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

16.2

162

761

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

15.7

459

3177

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

13.1

15.7

R05

ICPC

Cough

1.8

15.7

311

1914

KMAK

NOMESCO Finland

1.6

15.6

769

6106

L15

ICPC

Knee symptom/complaint

1.9

15.5

248

1414

H02AB06

ATC

prednisolone; systemic

1.6

15.4

571

4208

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

15.4

368

2400

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.8

15.4

181

R52.2

ICD-10 Finland

Other chronic pain

3.8

15.3

182

F41.3

ICD-10 Finland

Other mixed anxiety disorders

5.7

15.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

15.2

158

757

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

15.2

215

N04BC05

ATC

pramipexole; oral

3.0

15.0

306

L01

ICPC

Neck symptom/complaint

2.0

15.0

199

1057

N02CC04

ATC

rizatriptan; oral

2.5

15.0

120

502

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

9.0

15.0

S21

ICPC

Skin texture symptom/complaint

2.2

15.0

156

745

D07AA02

ATC

hydrocortisone; topical

2.0

14.9

208

1128

R52.9

ICD-10 Finland

Pain, unspecified

2.6

14.9

116

477

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.1

14.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

14.8

234

1330

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

14.8

162

794

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

21.3

14.7

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

14.7

243

30140

ICD-8 Finland

Personality disorders, Anankastic

+∞

14.6

N05BA02

ATC

chlordiazepoxide; systemic

5.9

14.6

X78

ICD-10 Finland

Intentional self-harm by sharp object

14.3

14.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

14.6

427

2944

-1

NOMESCO Finland

1.6

14.5

497

3572

R06AE07

ATC

cetirizine; oral

1.6

14.5

613

4647

P01AB01

ATC

metronidazole; oral, rectal

1.6

14.4

546

4027

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

14.3

262

1563

F84.5

ICD-10 Finland

Asperger syndrome

11.5

14.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

14.0

525

3853

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

9.5

14.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

14.0

248

1467

P20

ICPC

Memory disturbance

3.1

14.0

267

J01AA02

ATC

doxycycline; systemic

1.6

13.9

993

8517

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

13.8

541

4007

SPAT1153

SPAT

Removal of sutures

1.7

13.8

361

2405

J01FA06

ATC

roxithromycin; oral

1.6

13.8

524

3851

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

13.8

443

3125

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.9

13.7

307

R42

ICD-10 Finland

Dizziness and giddiness

1.9

13.5

229

1331

F34.0

ICD-10 Finland

Cyclothymia

16.4

13.5

SPAT1053

SPAT

Memory test

2.7

13.4

364

Z08

ICPC

Social welfare problem

6.6

13.4

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

13.4

137

651

M25.5

ICD-10 Finland

Pain in joint

1.6

13.3

383

2616

P28

ICPC

Limited function/disability (P)

10.6

13.3

U02

ICPC

Urinary frequency/urgency

2.0

13.2

168

875

WZA90

NOMESCO Finland

Other doctors statement

1.7

13.2

317

2056

Z00.0

ICD-10 Finland

General medical examination

1.8

13.2

230

1349

G44.2

ICD-10 Finland

Tension-type headache

1.9

13.1

203

1142

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

13.0

184

1000

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

13.0

578

4396

P15

ICPC

Chronic alcohol abuse

4.3

13.0

111

SPAT1254

SPAT

Administration of medicine

2.1

13.0

162

838

M79.1

ICD-10 Finland

Myalgia

2.0

13.0

183

992

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

12.9

432

3063

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

12.9

756

6128

F21

ICD-10 Finland

Schizotypal disorder

11.7

12.8

Z3226

NOMESCO Finland

Physiotherapist

1.8

12.8

228

1347

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

12.8

412

2894

G43.3

ICD-10 Finland

Complicated migraine

4.2

12.8

118

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

12.7

158

814

E0000UV

ATC

1.6

12.7

508

3764

R06AX13

ATC

loratadine; oral

1.8

12.7

244

1477

F50.0

ICD-10 Finland

Anorexia nervosa

7.6

12.7

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

12.6

136

660

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

12.6

141

697

J02AC01

ATC

fluconazole; systemic

1.5

12.6

582

4459

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

12.6

393

A03FA02

ATC

cisapride; oral, rectal

2.7

12.6

331

K02.1

ICD-10 Finland

Caries of dentine

1.5

12.5

807

6659

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

12.5

601

4642

F60.4

ICD-10 Finland

Histrionic personality disorder

+∞

12.5

R04

ICPC

Breathing problem other

3.5

12.5

166

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.4

12.4

102

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

7.7

12.4

R55

ICD-10 Finland

Syncope and collapse

2.4

12.4

109

479

J01DA01

ATC

[U] cefalexin; systemic

1.5

12.4

808

6681

SPAT1081

SPAT

Cardiorespiratory global assessment

3.5

12.3

168

F45.8

ICD-10 Finland

Other somatoform disorders

2.2

12.3

131

632

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.4

12.3

M03BX02

ATC

tizanidine; oral

1.5

12.2

851

7124

WX110

NOMESCO Finland

Local anesthesy

1.5

12.2

942

8074

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

12.2

375

2596

ZY000

NOMESCO Finland

Hospital inpatient

6.4

12.2

Z06

ICPC

Unemployment problem

7.8

12.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

12.1

146

745

R01AD08

ATC

fluticasone; nasal

1.6

12.1

405

2867

A02BC01

ATC

omeprazole; systemic

1.7

12.1

313

2070

N01

ICPC

Headache

2.0

12.0

170

924

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.9

11.9

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.9

11.9

179

994

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

11.7

116

544

R03BA05

ATC

fluticasone; inhalant

1.7

11.7

244

1514

F41.01

ICD-10 Finland

Severe panic disorder

7.8

11.7

F50.2

ICD-10 Finland

Bulimia nervosa

7.8

11.7

N05AE04

ATC

ziprasidone; systemic

7.8

11.7

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

12.7

11.6

SPAT1252

SPAT

Overall medication plan or its review

2.8

11.6

284

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

11.5

126

615

Z71.8

ICD-10 Finland

Other specified counselling

1.6

11.5

332

2256

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

11.5

235

1447

IGV01

NOMESCO Finland

Psychiatric network contact

10.1

11.5

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

10.1

11.5

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

10.1

11.5

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

121.0

11.4

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

11.4

234

1444

L08

ICPC

Shoulder symptom/complaint

1.8

11.4

221

1339

L04

ICPC

Chest symptom/complaint

2.6

11.3

333

L86

ICPC

Back syndrome with radiating pain

2.6

11.3

315

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

11.3

165

905

SPAT1234

SPAT

Support of social functional capacity

3.3

11.3

169

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

11.3

803

6697

F33.31

ICD-10 Finland

Recurrent depression, severe episode of somatic syndrome

35.3

11.3

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

6.3

11.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

11.2

235

1458

D07AC01

ATC

betamethasone; topical

1.6

11.2

406

2920

V03AA01

ATC

8.1

11.1

IEY01

NOMESCO Finland

Psychoeducation, individual

7.5

11.0

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.9

11.0

224

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

10.9

220

1349

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

10.9

102

463

G04BD07

ATC

tolterodine; oral

3.3

10.8

164

WX704

NOMESCO Finland

Intubation

2.3

10.8

105

487

R4140

NOMESCO Finland

Psychotherapy

8.3

10.8

R03DC03

ATC

montelukast; oral

1.7

10.8

230

1432

R03AC12

ATC

salmeterol; inhalant

3.2

10.8

181

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

10.7

10.8

S06.0

ICD-10 Finland

Concussion

2.0

10.7

133

684

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

6.8

10.7

R01AD09

ATC

mometasone; nasal

1.5

10.6

622

4955

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

10.6

517

3967

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

8.6

10.5

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

8.6

10.5

R06AX27

ATC

desloratadine; oral

1.5

10.5

398

2882

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

10.5

110

527

N06AA10

ATC

nortriptyline; systemic

3.8

10.5

115

IER01

NOMESCO Finland

Psychoeducation, group

9.3

10.5

N03AF01

ATC

carbamazepine; oral, rectal

2.9

10.5

225

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

7.4

10.5

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

110.8

10.4

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

10.3

126

645

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

18.9

10.3

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

10.3

111

542

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

10.2

252

1634

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

10.2

747

6204

G04BD04

ATC

oxybutynin; oral, transdermal

3.1

10.2

183

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.8

10.2

228

XF402

NOMESCO Finland

ECG with work load test

2.2

10.1

109

529

C05AA08

ATC

fluocortolone; rectal, topical

1.8

10.1

173

1005

F41.08

ICD-10 Finland

Mild or other specified panic syndrome

9.2

10.0

SPAT1139

SPAT

Nutrition survey

3.5

10.0

136

SPAT1312

SPAT

General health counselling

1.5

10.0

407

2987

P27

ICPC

Fear of mental disorder

5.8

10.0

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

9.9

113

564

J01FF01

ATC

clindamycin; systemic

1.6

9.9

334

2347

A27

ICPC

Fear of other disease NOS

2.9

9.9

204

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.7

9.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

9.8

215

1350

F50.3

ICD-10 Finland

Atypical bulimia nervosa

8.8

9.8

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

9.8

382

2780

L12

ICPC

Hand/finger symptom/complaint

1.8

9.7

177

1047

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.4

9.7

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

13.5

9.7

SBB10

NOMESCO Finland

Teeth copy

2.2

9.6

437

A29

ICPC

General symptom/complaint other

2.0

9.6

121

629

A11

ICPC

Chest pain NOS

2.4

9.6

332

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

9.6

103

499

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

9.6

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

10.1

9.5

K59.01

ICD-10 Finland

Constipation outlet obstruction type

7.2

9.5

R03AC03

ATC

terbutaline; inhalant

1.8

9.5

182

1097

E000001

ATC

1.6

9.4

266

1784

R21

ICPC

Throat symptom/complaint

1.6

9.4

302

2095

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

5.4

9.4

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

12.4

9.4

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

9.3

204

1279

J01DB01

ATC

cefalexin; oral

1.5

9.3

1077

9719

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

9.3

260

1745

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

13.8

9.2

C08DA01

ATC

verapamil; systemic

3.1

9.1

164

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.0

9.0

113

587

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.6

9.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

9.0

279

SPAT1058

SPAT

PEF monitoring instruction

2.1

9.0

486

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

9.0

174

L02

ICPC

Back symptom/complaint

1.9

9.0

128

697

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

24.2

8.9

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

8.9

158

927

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

3.5

8.9

117

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

8.9

200

1261

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.3

8.9

340

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.8

8.9

F29

ICPC

Eye symptom/complaint other

2.1

8.9

101

505

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

8.8

164

977

P25

ICPC

Phase of life problem adult

2.4

8.8

315

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

8.8

191

1192

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.7

8.8

103

R52.1

ICD-10 Finland

Chronic intractable pain

6.0

8.8

E66.8

ICD-10 Finland

Other obesity

2.2

8.7

390

N05CD02

ATC

nitrazepam; oral

7.2

8.7

S04

ICPC

Lump/swelling localized

2.0

8.7

112

584

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

8.7

106

543

D12

ICPC

Constipation

3.6

8.7

104

WX290

NOMESCO Finland

Other blockade of nerve

1.4

8.6

647

5327

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.7

8.6

222

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

8.6

157

931

M54.2

ICD-10 Finland

Cervicalgia

2.1

8.6

488

T83

ICPC

Overweight

3.8

8.6

ZXY60

NOMESCO Finland

2-person team, nurses

9.0

8.5

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

9.0

8.5

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

9.0

8.5

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.4

8.5

116

N04AA02

ATC

biperiden; systemic

4.3

8.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

8.5

104

533

SPAT1216

SPAT

Assessment of functional ability

1.9

8.5

122

665

L29

ICPC

Musculoskeletal sympt/complt other

2.2

8.5

406

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

8.5

104

534

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

8.5

296

N05AA01

ATC

chlorpromazine; systemic, rectal

5.4

8.5

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

8.5

N06AA22

ATC

7.4

8.5

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.0

8.4

165

RT134

NOMESCO Finland

90.6

8.4

ZXY84

NOMESCO Finland

Occupational therapist in multidisciplinary team

90.6

8.4

N17

ICPC

Vertigo/dizziness

2.0

8.4

112

595

UJF32

NOMESCO Finland

Coloscopy

1.6

8.4

261

1792

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.1

8.4

145

N05AH02

ATC

clozapine; systemic

3.9

8.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.3

148

869

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

10.8

8.3

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.2

8.3

130

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

8.3

241

D02

ICPC

Abdominal pain epigastric

2.2

8.2

374

R03BA01

ATC

beclometasone; inhalant

1.7

8.2

173

1069

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

8.2

143

836

WZB00

SPAT

2.3

8.1

334

M02AA07

ATC

piroxicam; topical

1.5

8.1

370

2762

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

4.2

8.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

8.1

310

2232

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

8.0

419

R74

ICPC

Upper respiratory infection acute

1.4

8.0

420

3223

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.1

8.0

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

10.1

8.0

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

8.0

313

2264

M01AC01

ATC

piroxicam; systemic, rectal

1.8

8.0

140

819

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

8.0

298

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

8.0

A97

ICPC

No disease

1.7

7.9

166

1025

F50.8

ICD-10 Finland

Other eating disorders

7.8

7.9

M01AH02

ATC

rofecoxib; oral

1.8

7.9

125

709

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

7.9

205

1344

IGP01

NOMESCO Finland

Psychiatric family contact

10.9

7.8

JAETT

NOMESCO Finland

10.9

7.8

ICA04

NOMESCO Finland

Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution

10.9

7.8

T90

ICPC

Diabetes non-insulin dependent

1.6

7.8

197

1284

D11

ICPC

Diarrhoea

1.7

7.8

153

927

SPAT1285

SPAT

Provision of consultation response

2.4

7.7

270

ZYD01

NOMESCO Finland

Emergency clinic

15.1

7.7

ZXY61

NOMESCO Finland

2-person team, special workers

15.1

7.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

7.7

378

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

7.7

278

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

7.7

313

2279

R01AD01

ATC

beclometasone; nasal

1.6

7.7

202

1327

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

7.7

190

1228

R51.81

ICD-10 Finland

Facial pain NOS

3.2

7.7

121

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

7.7

110

601

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

7.7

396

3027

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

7.7

105

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.1

7.6

127

SPAT1389

SPAT

Visit based on need for special support

3.1

7.6

127

N39.3

ICD-10 Finland

Stress incontinence

2.1

7.6

421

U01

ICPC

Dysuria/painful urination

2.1

7.6

421

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.7

7.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

7.6

126

725

L20

ICPC

Joint symptom/complaint NOS

2.8

7.6

177

EMAK

NOMESCO Finland

2.5

7.6

236

N05AB01

ATC

dixyrazine; systemic

6.2

7.5

K59.0

ICD-10 Finland

Constipation

2.6

7.5

203

A28

ICPC

Limited function/disability NOS

2.0

7.5

466

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

10.1

7.5

N05AE05

ATC

lurasidone; oral

10.1

7.5

S22

ICPC

Nail symptom/complaint

2.4

7.5

268

H50.52

ICD-10 Finland

Exophoria

4.2

7.5

SPAT1101

SPAT

Orthostatic test

3.3

7.5

107

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

7.5

241

1664

F10.24

ICD-10 Finland

Alcohol depence active use

4.4

7.5

C07AB02

ATC

metoprolol; systemic

1.7

7.5

155

955

L13

ICPC

Hip symptom/complaint

1.7

7.4

147

895

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.1

7.4

RT421

NOMESCO Finland

80.5

7.4

EBA00

NOMESCO Finland

Extraction of tooth

1.4

7.4

396

3044

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

7.4

176

1126

N02CC03

ATC

zolmitriptan; nasal, oral

2.0

7.4

465

R07.3

ICD-10 Finland

Other chest pain

1.9

7.3

524

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

7.3

306

F64.9

ICD-10 Finland

Gender identity disorder, unspecified

+∞

7.3

UKC02

NOMESCO Finland

Cystoscopy

1.8

7.3

125

725

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.1

7.3

126

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

7.3

134

2058

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

9.4

7.3

R68.2

ICD-10 Finland

Dry mouth, unspecified

9.4

7.3

T82

ICPC

Obesity

2.4

7.3

239

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

7.3

314

2311

M48.0

ICD-10 Finland

Spinal stenosis

2.0

7.3

474

G04BD12

ATC

mirabegron; oral

2.1

7.2

409

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

15.8

7.2

T05

ICPC

Feeding problem of adult

5.8

7.2

SPAT1395

SPAT

Health check-up of persons outside student and working life

3.2

7.2

116

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

7.2

338

2531

J01FA10

ATC

azithromycin; systemic

1.4

7.1

786

6820

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

7.1

102

560

N05AD01

ATC

haloperidol; systemic

3.4

7.1

WX892

NOMESCO Finland

Monitored bed care

2.1

7.1

345

ZXY52

NOMESCO Finland

2-person team, doctor-psychologist

10.1

7.0

ZXY03

NOMESCO Finland

Occupational therapist

10.1

7.0

R15

ICD-10 Finland

Faecal incontinence

3.6

7.0

L20.0

ICD-10 Finland

Besnier prurigo

1.9

7.0

106

590

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

7.0

117

675

RS220

NOMESCO Finland

5.2

6.9

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

6.9

340

C03CA01

ATC

furosemide; systemic

1.6

6.9

164

1047

N02AC04

ATC

dextropropoxyphene; oral

3.3

6.9

103

R06AE09

ATC

levocetirizine; oral

1.6

6.9

198

1331

S08

ICPC

Skin colour change

2.4

6.9

235

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.7

6.9

165

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

6.8

217

R08

ICPC

Nose symptom/complaint other

2.6

6.8

180

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

6.7

6.8

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

6.8

289

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.0

6.8

127

ZYC03

NOMESCO Finland

Remote contact, text-based

6.1

6.8

R35

ICD-10 Finland

Polyuria

2.3

6.8

270

ZYA02

NOMESCO Finland

Contact at day ward in specialised medical care or in other intensive outpatient care setting

40.2

6.8

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

40.2

6.8

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

6.8

351

N30.0

ICD-10 Finland

Acute cystitis

1.6

6.7

155

985

N05AX15

ATC

cariprazine; oral

16.8

6.7

ZXY81

NOMESCO Finland

Psychologist in multidisciplinary team

16.8

6.7

IEY03

NOMESCO Finland

Vocational rehabilitation

16.8

6.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

6.7

282

2062

K85

ICPC

Elevated blood pressure

1.8

6.7

115

669

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

6.7

417

K03.00

ICD-10 Finland

Approximal wear

2.2

6.7

319

G04BD08

ATC

solifenacin; oral

2.3

6.7

264

M01AB55

ATC

diclofenac, combinations; oral

2.2

6.7

297

H02

ICPC

Hearing complaint

1.9

6.7

495

S10

ICPC

Boil/carbuncle

2.2

6.7

298

D06

ICPC

Abdominal pain localized other

1.9

6.6

100

558

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

7.8

6.6

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

7.8

6.6

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

6.6

360

C01CA24

ATC

epinephrine; parenteral

1.9

6.6

514

E000007

ATC

2.1

6.6

374

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

6.6

374

K96

ICPC

Haemorrhoids

2.8

6.6

141

F30.0

ICD-10 Finland

Hypomania

12.3

6.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

6.6

276

2015

H29

ICPC

Ear symptom/complaint other

1.8

6.6

103

582

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

10.1

6.5

N03AF02

ATC

oxcarbazepine; oral

2.7

6.5

158

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.6

6.5

R03AC13

ATC

formoterol; inhalant

2.3

6.5

250

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

6.5

329

2498

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.4

6.5

WX720

NOMESCO Finland

Own respiration

2.4

6.4

212

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.5

6.4

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.6

6.4

168

F40.8

ICD-10 Finland

Other phobic anxiety disorders

7.4

6.4

K08.80

ICD-10 Finland

Toothache NOS

1.8

6.4

112

655

IHZ05

SPAT

2.9

6.4

131

SPAT1360

SPAT

Extensive global examination

2.0

6.4

416

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

6.4

521

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

6.4

285

2108

OAB48

SPAT

0.5

6.3

930

R03BA02

ATC

budesonide; inhalant

1.5

6.3

210

1461

Z91.5

ICD-10 Finland

Personal history of self-harm

11.1

6.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

6.3

101

577

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.8

6.3

140

H13

ICPC

Plugged feeling ear

1.6

6.3

159

1034

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

18.1

6.3

ZYY97

NOMESCO Finland

Missed treatment contact, notification given by patient

+∞

6.3

R03BC01

ATC

cromoglicic acid; inhalant

3.2

6.2

Z2230

NOMESCO Finland

Head nurse

26.8

6.2

ICA03

NOMESCO Finland

Psychiatric treatment plan, outsourced psychotherapy

26.8

6.2

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

6.2

443

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

7.1

6.2

K07.24

ICD-10 Finland

Open bite

4.1

6.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

6.2

436

3494

K03.80

ICD-10 Finland

Irradiated enamel

2.1

6.2

323

R05

ICD-10 Finland

Cough

1.5

6.2

206

1432

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

6.2

159

EBA30

NOMESCO Finland

Excision of root of tooth

2.3

6.2

234

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

6.2

129

799

A02BA04

ATC

nizatidine; systemic

2.0

6.2

351

C09CA06

ATC

candesartan; oral

1.5

6.2

222

1571

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

7.7

6.1

M01AE02

ATC

naproxen; oral, rectal

1.3

6.1

720

6243

VALMI

NOMESCO Finland

1.4

6.1

329

2516

P58

ICPC

Psychological, Therapeutic counselling/listening

3.0

6.1

108

U04

ICPC

Incontinence urine

2.7

6.1

137

M35.7

ICD-10 Finland

Hypermobility syndrome

3.1

6.1

ZXY56

NOMESCO Finland

2-person team, nurse-psychologist

12.6

6.1

X84

ICD-10 Finland

Intentional self-harm by unspecified means

12.6

6.1

Z2221

NOMESCO Finland

Medical doctor

1.4

6.1

330

2531

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

6.1

536

R09

ICPC

Sinus symptom/complaint

1.7

6.1

111

660

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

8.6

6.1

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

6.1

487

WX402

NOMESCO Finland

General anaesthesia

1.5

6.0

200

1390

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

6.0

455

3686

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

423

1750

2.97

71.79

1.9

1.7

1.5

1.4

2.10

381

1569

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

838

4903

2.60

71.13

5.9

6.3

mmol/l

1.2

1.42

724

4155

(3019309) Folate [Moles/volume] in Red Blood Cells

375

1470

3.07

69.87

1.7

1.6

nmol/l

1254.3

1173.8

0.92

301

1154

(3011288) Drugs identified in Urine by Screen method

188

471

4.42

68.94

3.6

2.3

—

(3028707) Methadone [Presence] in Urine by Screen method

138

271

5.51

67.63

3.4

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

712

3977

2.50

64.93

2.0

1.7

pmol/l

97.8

98.0

0.04

392

2138

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1312

9943

3.49

61.94

5.4

4.0

pmol/l

14.2

14.5

5.56

1240

9266

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

748

4380

2.41

60.06

5.1

5.6

mmol/l

1.2

1.50

689

4010

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1206

8860

2.82

57.47

7.0

u/l

73.0

74.7

1.04

1149

8352

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

9.80

55.41

11.5

11.9

mmol/l

0.6

1.30

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

708

4150

2.33

55.41

3.6

3.1

u/l

27.9

30.0

1.95

669

3951

(3024561) Albumin [Mass/volume] in Serum or Plasma

725

4396

2.25

51.10

4.3

4.6

g/l

37.2

36.6

2.61

680

4123

(3018418) pH of Serum or Plasma

534

2851

2.35

51.02

3.5

3.9

7.4

1.27

547

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

774

4855

2.22

49.74

2.6

2.2

nmol/l

77.1

75.1

1.03

728

4485

(1001926) Buprenorphine [Presence] in Urine by Screen method

176

536

3.59

48.59

3.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

279

1119

2.83

48.33

2.0

2.1

nmol/l

365.0

369.3

0.16

257

1045

(3015377) Calcium [Moles/volume] in Serum or Plasma

602

3466

2.23

47.23

2.5

3.2

mmol/l

2.3

2.4

1.38

536

3112

(3021960) Folate [Moles/volume] in Serum or Plasma

423

2118

2.39

46.05

1.6

1.4

nmol/l

20.8

0.03

384

1860

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

408

2056

2.35

43.43

1.7

1.6

pmol/l

77873992.1

40056447.2

0.37

348

1785

(3009508) Creatinine [Moles/volume] in Urine

546

3124

2.17

42.53

3.2

mmol/l

8.3

8.0

0.65

477

2690

(3016879) Cocaine [Presence] in Urine

186

647

3.14

41.26

2.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

196

706

3.04

40.92

2.8

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

872

6013

2.07

40.64

3.3

2.7

ug/l

81.8

94.5

1.38

813

5672

(3027008) Opiates [Presence] in Urine

196

713

3.01

40.19

2.8

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1155

8883

2.29

40.15

4.4

3.7

mm/h

9.4

9.9

0.82

1100

8315

(3028300) Cannabinoids [Presence] in Urine

196

714

3.01

40.08

2.9

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1389

11672

3.47

39.79

6.7

4.6

mu/l

1.7

2.0

1.21

1328

10971

(3027944) Amphetamines [Presence] in Urine

189

705

2.92

36.93

1.8

1.7

—

(3044889) 12 lead EKG panel

1056

7966

2.09

36.65

3.9

3.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1434

12464

4.19

35.26

15.4

11.2

mmol/l

139.7

139.6

0.24

1420

12120

(3023103) Potassium [Moles/volume] in Serum or Plasma

1436

12508

4.23

34.86

15.5

11.2

mmol/l

3.9

0.10

1420

12138

(3009466) Valproate [Moles/volume] in Serum or Plasma

146

5.20

34.82

4.9

5.7

umol/l

355.3

367.7

0.28

126

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

567

3489

2.00

34.76

3.0

2.5

u/l

56.1

56.3

0.06

527

3264

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

455

2615

2.06

33.52

2.4

2.0

mg/l

2.5

2.8

2.26

400

2252

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

819

5763

1.92

33.30

5.2

5.9

umol/l

9.9

10.6

1.45

770

5468

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

499

2978

2.01

33.01

2.3

2.0

u/l

279.0

175.7

0.51

478

2830

(3013650) Neutrophils [#/volume] in Blood by Automated count

935

6934

1.92

31.74

9.3

8.7

e9/l

3.9

4.0

0.60

834

6151

(3019150) Specific gravity of Urine by Refractometry

434

2520

2.01

30.63

3.3

kg/l

1.0

1.64

361

(3013115) Eosinophils [#/volume] in Blood

859

6245

1.87

30.47

6.0

e9/l

0.2

0.05

764

5599

(42870588) Differential panel, method unspecified - Blood

587

3801

1.89

29.83

4.9

6.0

—

(3001604) Monocytes [#/volume] in Blood

831

6011

1.85

29.61

5.8

e9/l

0.5

0.61

725

5309

(3006315) Basophils [#/volume] in Blood

833

6032

1.85

29.56

5.8

e9/l

0.0

0.47

727

5322

(3003458) Phosphate [Moles/volume] in Serum or Plasma

248

1180

2.32

29.04

3.8

6.0

mmol/l

1.0

0.64

230

1116

(3022948) Iron [Moles/volume] in Serum or Plasma

295

1516

2.18

28.63

2.0

2.3

umol/l

14.6

14.2

0.38

281

1407

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1371

11881

2.73

28.46

5.0

3.7

mmol/l

5.8

5.7

0.54

1300

11098

(44816559) Phosphatidylethanol [Mass/volume] in Blood

263

3.66

27.68

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

272

1372

2.20

27.57

1.9

2.3

g/l

2.5

2.4

2.19

247

1276

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

503

3192

1.86

26.54

1.4

1.3

u/ml

1.3

1.4

0.08

126

890

(3019198) Lymphocytes [#/volume] in Blood

839

6228

1.78

26.06

5.8

e9/l

1.9

2.0

0.37

750

5606

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

194

874

2.40

25.57

2.9

3.3

pmol/l

4.5

0.76

163

787

(3012095) Magnesium [Moles/volume] in Serum or Plasma

295

1608

2.04

24.14

2.8

3.5

mmol/l

0.8

1.18

276

1525

(3013826) Glucose [Moles/volume] in Serum or Plasma

851

6435

1.74

23.91

4.9

4.3

mmol/l

6.4

6.5

0.55

793

5907

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1103

9007

1.84

23.57

4.2

2.9

u/l

44.3

41.9

0.37

1035

8584

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1273

10907

2.08

23.39

5.7

4.6

mmol/mol

38.1

38.3

0.47

1200

10291

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

243

1248

2.13

23.26

2.0

2.3

23.8

24.2

0.17

199

1083

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

10.16

22.98

1.9

2.7

umol/l

13.8

17.7

0.79

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1459

13357

4.02

22.12

15.7

11.9

umol/l

71.2

71.3

0.08

1459

13352

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

5.37

21.62

1.2

1.9

—

(3022096) Basophils/100 leukocytes in Blood

735

5453

1.68

21.13

5.5

5.9

0.7

0.03

684

5128

(3006504) Eosinophils/100 leukocytes in Blood

753

5652

1.66

20.47

5.7

5.8

2.8

0.25

704

5300

(3048689) Calprotectin [Mass/mass] in Stool

301

1754

1.90

19.94

2.0

2.4

ug/g

89.3

107.2

0.78

223

1392

(3019069) Monocytes/100 leukocytes in Blood

751

5691

1.64

19.21

6.0

6.1

8.3

8.2

0.04

703

5383

(36660697) Celiac disease serology panel - Serum

209

1094

2.06

18.81

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

287

1689

1.86

18.30

2.3

2.7

mmol/l

2.4

1.84

247

1493

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

5.70

17.78

3.2

2.9

—

(3018010) Neutrophils/100 leukocytes in Blood

758

5837

1.60

17.57

5.7

5.6

55.8

56.5

1.08

709

5517

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

130

577

2.37

17.56

2.5

2.6

ng/l

74.0

133.9

2.20

119

516

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

455

3096

1.67

17.38

1.9

1.6

mmol/l

1.5

1.4

1.16

381

2688

(3002030) Lymphocytes/100 leukocytes in Blood

764

5905

1.60

17.35

5.8

30.0

29.1

1.61

710

5567

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

145

681

2.25

17.17

3.0

3.8

ng/l

78.9

78.4

0.02

127

613

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1451

13474

3.14

16.73

11.8

8.9

u/l

28.9

26.5

1.75

1425

13076

(3012516) Albumin [Mass/volume] in Urine

406

2711

1.68

16.52

3.2

3.3

mg/l

1051.3

305.1

1.12

246

1729

(3037467) Urinalysis macro (dipstick) panel - Urine

1008

8374

1.62

16.48

4.4

3.9

—

(3037522) Nuclear Ab [Titer] in Serum

300

1846

1.78

16.36

1.4

titre

362.1

557.0

1.60

387

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

302

1873

1.77

16.00

3.9

3.1

ng/l

95.8

414.3

3.51

190

1186

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

346

2232

1.71

15.93

1.4

1.3

u/ml

13.3

10.4

0.13

109

956

(3031040) Bacteria [#/volume] in Urine by Automated count

955

7877

1.58

15.67

4.6

3.7

e6/l

60.5

835.8

1.09

(3032080) INR in Blood by Coagulation assay

526

3813

1.58

15.10

7.0

6.2

inr

1.1

0.17

169

1213

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

356

2348

1.68

14.98

1.4

1.3

iu/ml

18.8

29.1

1.95

751

(3016502) Oxygen saturation in Arterial blood

163

845

2.04

14.95

6.7

9.2

96.9

96.1

2.03

155

819

(3007164) IgA [Mass/volume] in Serum or Plasma

403

2746

1.64

14.93

1.4

g/l

2.3

0.01

250

1769

(3020682) Albumin/Creatinine [Ratio] in Urine

414

2847

1.63

14.75

3.8

4.0

mg/mmol

6.2

8.8

0.56

245

1801

(3008152) Bicarbonate [Moles/volume] in Arterial blood

111

503

2.30

14.29

5.4

8.8

mmol/l

24.7

24.4

0.36

101

468

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

514

3747

1.56

14.21

3.6

2.8

ng/l

31.7

40.7

0.44

269

2021

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1379

12645

2.08

14.15

14.0

10.9

mg/l

18.9

20.7

1.38

1104

9757

(3021387) Prolactin [Units/volume] in Serum or Plasma

142

715

2.09

14.07

1.8

1.6

mu/l

366.1

298.9

0.82

125

645

(3047181) Lactate [Moles/volume] in Blood

298

2.67

13.89

5.3

7.7

mmol/l

1.2

0.11

257

(3017446) Testosterone [Moles/volume] in Serum or Plasma

155

812

2.01

13.79

3.1

2.1

nmol/l

10.9

12.6

1.79

139

738

(3026008) Bacteria identified in Urine by Culture

431

3036

1.59

13.74

2.8

2.4

—

(3023368) Bacteria identified in Blood by Culture

359

2428

1.63

13.52

3.5

4.0

—

(3042517) Benzodiazepines panel - Urine

13.10

13.38

1.8

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

184

1033

1.89

13.35

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

246

1524

1.73

12.87

1.8

—

(4010399)

143

747

2.01

12.81

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

172

958

1.90

12.78

6.5

8.5

kpa

5.0

5.1

1.06

164

918

(3027801) Oxygen [Partial pressure] in Arterial blood

172

958

1.90

12.78

6.5

8.5

kpa

12.6

12.9

0.44

164

921

(3002385) Erythrocyte distribution width [Ratio]

1234

11021

1.66

12.74

17.7

12.9

13.4

13.5

1.16

1217

10788

(3003396) Base excess in Arterial blood by calculation

170

948

1.89

12.58

6.6

8.6

mmol/l

1.2

0.9

0.48

130

735

(3021589) Normoblasts [#/volume] in Blood

680

5370

1.49

12.45

8.6

8.3

e9/l

0.0

0.41

571

4422

(3000494) Fungus identified in Specimen by Culture

225

1372

1.75

12.42

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

178

1018

1.85

12.16

1.7

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

746

6032

1.47

11.94

4.5

4.3

estimate

0.0

0.50

132

1190

(3002173) Hemoglobin [Mass/volume] in Arterial blood

148

804

1.93

11.84

6.8

9.5

g/l

126.2

122.3

1.56

141

776

(3035350) Ketones [Presence] in Urine by Test strip

743

6011

1.47

11.81

3.4

3.1

estimate

0.0

0.50

122

1151

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

128

663

2.02

11.73

2.1

ug/l

6.6

7.6

0.23

114

600

(3042936) Bacteria identified in Isolate by Culture

237

1500

1.69

11.39

2.0

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

188

1119

1.78

11.24

1.2

iu/ml

86.7

144.2

1.48

437

(3009261) Glucose [Presence] in Urine by Test strip

747

6087

1.45

11.21

3.4

3.1

estimate

0.0

0.80

128

1135

(3023323) Follitropin [Units/volume] in Serum or Plasma

164

938

1.84

11.18

1.3

iu/l

24.0

25.1

0.16

142

798

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.59

11.18

2.1

1.7

umol/l

108.0

127.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1359

12570

1.84

11.06

5.3

4.1

mmol/l

2.9

1.02

1281

11852

(40761535) Cells panel - Urine sediment

146

816

1.87

10.70

3.2

3.3

—

(3019060) Gas panel - Arterial blood

104

526

2.05

10.19

4.1

6.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

381

2765

1.51

10.13

1.6

1.7

mg/l

0.9

1.0

0.43

280

2049

(3009214) Lutropin [Units/volume] in Serum or Plasma

486

2.09

10.12

1.4

1.3

u/l

8.9

10.4

0.43

399

(3000850) Epithelial cells [#/volume] in Urine

311

2166

1.55

10.00

2.1

2.3

e6/l

6.8

0.00

274

1895

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1342

12437

1.73

9.90

4.8

3.8

mmol/l

4.7

4.8

2.50

1272

11808

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

463

2.10

9.88

9.5

11.7

—

(40758558) Short blood count panel - Blood

401

2954

1.49

9.87

6.4

6.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

229

1493

1.63

9.73

1.9

2.1

28.2

29.4

3.87

221

1447

(3007853) Bacteria identified in Skin by Aerobe culture

208

1326

1.66

9.65

1.9

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

297

2.35

9.58

1.3

1.4

ug/g

306.5

305.9

0.01

161

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

177

1083

1.72

9.57

2.9

2.4

u/l

38.5

85.2

0.53

152

929

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

304

2129

1.54

9.49

2.8

2.7

ng/l

463.3

727.3

2.35

256

1745

(3030467) Casts [#/volume] in Urine by Automated count

391

2894

1.47

9.32

2.7

e6/l

0.4

0.07

304

2133

(3002032) Base excess in Venous blood by calculation

131

740

1.84

9.29

3.4

3.5

mmol/l

1.8

1.9

0.14

107

589

(3015171) Extractable nuclear Ab [Units/volume] in Serum

104

546

1.97

9.20

1.3

u/ml

1.0

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

279

2.35

9.07

1.5

e6/l

562.5

767.3

0.16

227

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

188

1191

1.66

8.92

6.9

5.3

—

(21494755) Public health laboratory ask at order entry panel

106

1858

0.54

8.77

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

279

2.31

8.62

1.6

1.4

e6/l

9.5

13.2

0.34

218

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

425

2.06

8.62

1.0

1.1

u/ml

2.6

4.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

132

2.93

8.47

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

471

1.99

8.40

2.3

2.2

—

(36304419) Bacteria [Presence] in Urine

384

2883

1.45

8.38

2.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1330

12396

1.63

8.35

4.6

3.8

mmol/l

1.4

1.5

5.39

1258

11721

(3044290) Cell count panel - Cerebral spinal fluid

264

2.33

8.34

1.6

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1596

0.52

8.33

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

121

690

1.82

8.33

1.6

1.7

—

(4198724)

3.86

8.26

2.1

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

315

2290

1.47

8.09

2.1

2.0

—

(40761511) CBC panel - Blood by Automated count

1420

13494

1.93

8.08

14.1

10.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

172

1096

1.64

7.96

5.8

6.9

mmol/l

104.0

104.5

0.73

163

1074

(3002582) Erythrocytes [#/volume] in Urine

415

3186

1.42

7.95

2.8

e6/l

47.5

54.4

0.15

334

2398

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

151

932

1.69

7.90

2.4

au/ml

20.1

20.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

356

2661

1.44

7.89

3.6

3.1

—

(1616796) Gas panel - Central venous blood

186

2.52

7.70

1.7

2.8

—

(3018095) Leukocytes [#/volume] in Urine

494

3931

1.38

7.60

3.4

3.2

e6/l

61.7

65.6

0.06

364

2618

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

140

859

1.69

7.49

1.3

au/ml

59.4

41.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

196

2.44

7.39

2.6

2.2

mmol/l

24.5

25.1

0.50

177

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

400

1.97

7.07

5.0

3.5

mmol/l

24.2

0.01

365

(3013139) Helicobacter pylori Ag [Presence] in Stool

135

835

1.68

7.01

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

130

2.73

6.95

1.3

1.4

nmol/l

—

(3026782) Osmolality of Urine

273

2003

1.44

6.58

2.3

2.4

mosm/kgh2o

515.9

552.6

1.71

230

1718

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

336

2559

1.40

6.58

2.2

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

144

921

1.62

6.57

2.3

g/l

0.2

0.34

126

877

(3014111) Lactate [Moles/volume] in Serum or Plasma

127

788

1.67

6.53

6.5

6.9

mmol/l

1.3

0.33

122

761

(3029937) Albumin [Presence] in Urine by Test strip

403

3169

1.37

6.50

3.9

3.4

estimate

0.0

1.49

127

1160

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

138

883

1.62

6.29

2.6

2.2

ml/min/173m2

77.4

75.2

0.24

322

(3000991) Gas panel - Venous blood

116

710

1.69

6.28

7.4

8.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

568

4723

1.33

6.28

3.5

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

231

2.20

6.27

1.7

1.5

—

(3022145) Colonoscopy Study observation

186

1282

1.51

6.13

1.2

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

346

1.95

5.95

5.4

6.9

1.9

1.6

1.04

324

(3005322) IgE [Units/volume] in Serum or Plasma

143

936

1.58

5.94

1.3

u/ml

114.0

214.9

1.75

131

866

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

122

770

1.64

5.88

3.0

3.5

mmol/l

1.2

0.03

666

(3007461) Platelets [#/volume] in Blood

1480

14408

2.64

5.87

22.5

16.0

e9/l

262.7

259.6

1.20

1460

14100

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1357

0.57

5.83

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1270

11907

1.43

5.81

4.2

3.5

mmol/l

1.4

1.3

4.35

1191

11240

(3021901) Oxygen saturation in Capillary blood

137

2.52

5.80

2.2

2.1

—

(3009343) pH of Capillary blood

548

1.74

5.79

2.5

3.0

7.4

0.09

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

218

1569

1.46

5.79

2.1

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

460

1.80

5.72

2.0

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

672

0.41

5.63

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

553

1.73

5.62

2.6

3.0

kpa

5.1

0.13

526

(3008295) Osmolality of Serum or Plasma

104

2.72

5.61

1.7

mosm/kgh2o

285.1

284.0

0.10

(3024731) MCV [Entitic volume]

1480

14423

2.57

5.57

22.5

15.9

90.5

90.3

0.79

1473

14264

(3035941) MCH [Entitic mass]

1480

14425

2.56

5.53

22.5

15.9

30.3

30.2

1.61

1473

14264

(3026361) Erythrocytes [#/volume] in Blood

1480

14426

2.56

5.51

22.6

15.9

e12/l

4.5

0.73

1457

14102

(3010813) Leukocytes [#/volume] in Blood

1480

14428

2.55

5.48

22.6

16.0

e9/l

6.6

6.7

0.27

1456

14094

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

236

1742

1.42

5.46

2.4

e6/l

1.1

1.3

0.13

138

951

(40768443) Skin Pathology biopsy report

445

1.79

5.44

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1480

14433

2.53

5.38

22.7

16.0

g/l

136.4

136.5

0.09

1473

14271

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

531

1.72

5.32

2.2

3.0

mmol/l

1.5

1.4

0.13

394

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1112

0.55

5.29

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

156

2.34

5.28

1.7

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

108

2.62

5.24

2.0

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

135

899

1.55

5.22

2.2

2.8

1.8

1.7

0.32

126

816

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

123

803

1.58

5.18

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.50

5.18

2.3

2.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

147

1002

1.52

5.11

3.6

4.7

u/l

213.7

241.1

1.98

140

952

(3022217) INR in Platelet poor plasma by Coagulation assay

146

994

1.52

5.11

13.9

15.0

inr

1.2

0.08

156

(3033658) Prothrombin time (PT) actual/Normal

355

2830

1.33

5.08

3.9

3.5

96.3

95.4

0.30

344

2746

(40768797) Stomach Pathology biopsy report

213

1566

1.42

5.03

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

353

1.85

5.00

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

180

2.20

4.96

1.3

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

392

1.80

4.90

2.0

1.9

g/l

0.2

0.04

371

(3023520) Reticulocytes [#/volume] in Blood

625

1.63

4.81

2.5

3.0

e9/l

73.6

71.7

0.21

457

(42529406) Shigella sp [Presence] in Stool by Culture

358

1.82

4.79

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

354

1.81

4.66

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.36

4.61

1.1

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

284

1.90

4.55

1.5

1.3

u/l

25.4

22.5

0.22

241

(3006653) Thiamine [Moles/volume] in Blood

3.08

4.52

1.6

nmol/l

140.6

146.6

0.24

(3005719) IgG [Mass/volume] in Serum or Plasma

137

945

1.49

4.52

2.0

2.6

g/l

9.9

10.5

1.09

129

872

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

2.71

4.42

1.1

1.4

u/l

4.7

6.8

1.40

(3018405) Lactate [Moles/volume] in Arterial blood

287

1.88

4.41

2.2

4.6

mmol/l

1.5

1.4

0.29

281

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

102

663

1.58

4.41

1.4

1.7

mg/l

2.9

4.2

0.61

452

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

135

935

1.49

4.37

2.1

2.2

u/l

7351.0

5800.9

0.14

397

(3003181) Sodium [Moles/volume] in Urine

125

2.35

4.35

1.4

1.3

mmol/l

66.7

68.3

0.06

108

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

520

0.41

4.32

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

408

1.72

4.31

1.8

g/l

1.2

0.12

386

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.57

4.30

5.5

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.57

4.30

5.5

2.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

297

1.85

4.29

2.0

2.3

ug/l

176.8

259.2

0.53

274

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

298

1.84

4.25

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

372

3051

1.29

4.25

4.0

4.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

598

0.46

4.25

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

2.28

4.24

1.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

582

1.60

4.22

1.4

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

179

1320

1.40

4.16

2.7

2.6

umol/l

8.1

6.8

0.37

152

1142

(1761868) Lipid panel - Serum or Plasma

444

5213

0.79

4.16

2.7

2.4

—

(3023410) Appearance of Cerebral spinal fluid

129

2.27

4.07

2.1

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

112

760

1.51

4.02

6.5

8.0

mmol/l

6.9

8.0

1.46

106

736

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

10.04

4.01

1.3

pmol/l

11.1

8.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

500

1.61

3.85

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.81

3.80

1.0

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

379

1.69

3.74

3.0

2.3

0.8

0.7

0.82

364

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

304

1.77

3.72

1.6

1.4

nmol/l

0.2

0.5

4.15

255

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

213

1646

1.34

3.71

2.6

2.5

e6/l

2.5

3.1

0.57

116

859

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

196

1.96

3.69

1.9

2.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

235

1844

1.33

3.69

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

515

1.58

3.65

1.6

1.5

—

(3020891) Body temperature

322

1.73

3.61

4.4

5.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.41

3.57

2.7

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

144

1936

0.72

3.56

1.4

—

(3013512) EKG study

339

2805

1.27

3.55

3.9

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

381

1.65

3.42

1.3

u/ml

43.1

34.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

223

1757

1.32

3.40

1.6

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

877

0.60

3.39

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

336

1.69

3.38

2.1

g/l

1.4

0.05

292

(3039443) Prostate specific Ag panel - Serum or Plasma

209

0.28

3.35

1.8

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1239

11805

1.28

3.31

11.6

9.4

ml/min/173m2

91.2

89.6

1.93

1023

9598

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

554

1.53

3.26

2.2

2.1

u/l

41.9

39.5

0.51

511

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

1234

1.36

3.26

1.9

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

103

2.25

3.23

1.7

1.1

—

(3003338) MCHC [Mass/volume]

1206

11473

1.26

3.13

20.5

13.3

g/l

333.9

333.1

2.32

1201

11395

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

3.10

0.0

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

767

0.60

3.04

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

133

2.05

3.02

1.9

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

2.33

2.92

1.5

—

(40768804) Tissue Pathology biopsy report

568

5053

1.20

2.90

1.9

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

345

1.62

2.85

1.3

u/ml

21.4

2.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

531

1.49

2.83

1.8

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

405

3504

1.21

2.75

2.8

2.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

594

0.58

2.66

1.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

206

1.77

2.63

1.4

2.1

g/l

134.6

133.3

0.11

154

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

369

1.57

2.62

1.7

2.1

iu/l

3.7

4.6

0.53

151

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

177

1.83

2.61

1.4

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

577

0.58

2.59

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

575

0.58

2.56

1.2

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

308

1.61

2.55

2.0

2.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

101

738

1.40

2.55

1.6

1.8

g/l

1.2

1.3

1.07

692

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.43

2.54

1.1

1.2

u/l

414.7

428.0

0.02

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.61

2.53

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

349

1.57

2.51

1.3

u/ml

2.6

9.8

—

(3030313) Adrenal Ab [Titer] in Serum

4.39

2.47

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

303

1.60

2.46

1.2

u/ml

71.9

44.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

167

1.81

2.41

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

160

1.83

2.40

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

2.13

2.39

1.3

1.1

nmol/l

407.6

408.3

0.01

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

146

1.86

2.38

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.27

2.37

1.6

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

6.27

2.37

6.6

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1275

12298

1.24

2.37

16.9

11.3

40.0

40.3

0.78

903

9928

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.16

2.35

1.5

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

176

1.78

2.35

1.8

2.0

17.0

17.1

0.03

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

278

1.60

2.27

1.2

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.63

2.27

2.5

11.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.63

2.27

1.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

699

0.65

2.25

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

698

0.65

2.24

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

698

0.65

2.24

1.2

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

450

1.46

2.23

9.8

10.3

mmol/l

24.3

24.2

0.13

433

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.12

2.22

3.3

4.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

277

2356

1.22

2.22

4.0

4.1

ug/l

1.5

2.0

1.42

254

2156

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

296

1.57

2.21

1.2

u/ml

358.8

247.2

1.13

189

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

696

0.65

2.21

1.2

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

100

2.01

2.21

1.3

e6/l

23327.9

108151.2

0.62

(3003694) ABO and Rh group [Type] in Blood

361

4109

0.84

2.20

1.5

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

321

1.54

2.18

1.8

2.1

ug/l

2.1

1.8

0.07

290

(3010421) pH of Blood

234

1.64

2.18

2.1

3.4

7.4

0.64

199

(3024928) Oxygen saturation in Venous blood

182

1.72

2.12

3.2

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

633

1.38

2.12

1.8

—

(3002619) Bacteria identified in Specimen by Culture

3.21

2.09

1.5

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.09

2.07

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

122

952

1.31

2.06

3.4

4.4

0.7

0.8

0.26

261

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

103

1.95

2.05

2.6

32.9

32.7

0.05

103

(3048929) Epstein Barr virus Ab [Presence] in Serum

544

1.40

2.03

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.01

2.00

1.1

1.5

pmol/l

122.3

56.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

363

0.54

2.00

1.7

1.4

pmol/l

45.7

116.9

1.46

354

(3012501) Base excess in Blood by calculation

201

1.66

1.99

1.9

3.5

mmol/l

1.2

2.3

2.34

129

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

148

1.77

1.99

1.0

1.2

—

(3019225) pH of Specimen

124

976

1.29

1.97

3.0

3.9

—

(3025941) Bacteria identified in Stool by Culture

100

764

1.33

1.96

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

356

1.48

1.92

2.4

2.5

g/l

3.7

3.5

0.30

336

(3021440) Promyelocytes/100 leukocytes in Blood

116

909

1.30

1.91

3.6

4.5

0.1

0.2

0.19

242

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

634

5840

1.15

1.89

4.1

3.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

114

1.85

1.87

1.2

1.3

u/ml

0.3

0.4

0.12

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.54

1.84

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

279

1.52

1.80

1.5

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

263

1.54

1.80

1.2

1.4

u/ml

95.4

103.4

0.24

(3034860) Kappa light chains.free [Mass/volume] in Serum

223

1.58

1.80

2.1

4.0

mg/l

25.5

67.8

0.88

182

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.05

1.80

1.0

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

255

1.54

1.80

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

138

1.75

1.80

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

312

1.49

1.79

1.2

—

(3008898) HLA-B27 [Presence]

609

1.35

1.79

1.1

—

(3025159) Blasts/100 leukocytes in Blood

109

856

1.29

1.78

3.5

4.6

0.0

0.5

0.73

207

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

1.67

1.77

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

216

1.59

1.77

2.1

4.0

ratio

1.3

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

464

1.40

1.77

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

365

3245

1.16

1.76

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.10

1.76

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

310

0.54

1.76

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

265

1.52

1.75

2.5

2.9

—

(4306422)

225

1.57

1.74

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

381

1.43

1.74

1.8

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

1.50

1.73

2.1

2.4

g/l

2.9

3.0

0.53

240

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

335

2962

1.17

1.73

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

220

1877

1.20

1.72

4.2

3.6

20.2

21.1

0.33

765

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

424

1.41

1.72

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.85

1.71

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

171

1.65

1.71

2.1

4.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.96

1.69

1.8

2.5

41.9

43.6

—

(4027681)

104

1.84

1.67

1.1

1.3

—

(3002256) Pathology report gross observation

182

1530

1.22

1.66

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

119

1.78

1.66

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

165

1.65

1.4

—

(3045414) Leukocytes [Presence] in Urine

548

1.35

1.65

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.47

1.64

2.1

2.4

g/l

3.7

0.01

234

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.47

1.64

2.1

2.4

g/l

6.9

7.2

0.54

251

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.47

1.64

2.1

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

286

1.48

1.63

1.2

1.4

—

26.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.33

1.60

4.3

3.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.51

1.59

2.6

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

423

1.39

1.57

1.8

2.2

—

(3045716) Anion gap in Serum or Plasma

2.21

1.57

1.5

1.8

mmol/l

9.2

9.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.86

1.56

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

1.89

1.55

1.1

1.2

—

(3036489) Thrombin time

459

1.37

1.54

2.1

2.0

25.2

21.1

0.87

398

(3037756) Immunofixation for Serum or Plasma

153

1.64

1.53

1.3

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.28

1.53

1.1

3.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

1.81

1.53

1.0

1.1

u/l

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.60

1.51

1.0

mg/g

4.4

5.8

—

(4281824)

129

0.39

1.48

1.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

168

0.47

1.47

2.5

2.7

u/ml

5.6

5.7

—

151

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.23

1.46

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.85

1.46

1.5

22.7

33.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

323

2886

1.15

1.45

2.2

2.4

umol/l

1055.3

4163.3

2.49

278

2578

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.45

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

188

1.55

1.43

1.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

390

3535

1.14

1.42

2.0

1.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

109

884

1.25

1.42

3.4

4.3

0.4

0.5

0.29

198

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

229

1.50

1.42

1.8

2.6

g/l

0.0

0.16

224

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

173

1.57

1.40

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

173

1.57

1.40

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

263

1.46

1.40

1.8

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

305

1.42

1.39

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

120

0.41

1.37

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.61

1.37

1.7

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.95

1.36

1.4

1.7

—

(3017704) Immunofixation for Urine

2.14

1.33

1.1

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

102

828

1.25

1.33

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.04

1.33

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

377

1.37

1.32

2.3

2.4

175.0

169.4

0.17

363

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

225

1.48

1.32

4.4

3.3

u/ml

0.4

0.3

0.23

122

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

656

0.74

1.29

1.3

miu/ml

238.8

232.9

0.03

340

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1.42

1.29

2.2

2.5

g/l

10.4

10.3

0.05

248

(3024980) IgG subclass 4 [Mass/volume] in Serum

202

1.50

1.27

1.2

1.7

g/l

0.7

0.8

0.35

150

(4062490)

122

1.65

1.27

1.0

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

146

1.58

1.26

1.4

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

118

0.42

1.24

3.8

1.5

g/l

1.2

1.0

—

118

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

399

1.34

1.23

1.3

1.2

—

(4035726)

962

0.79

1.23

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.97

1.22

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.73

1.21

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1046

0.80

1.20

1.7

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.75

1.19

1.0

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

367

1.35

1.19

2.3

3.4

mmol/l

24.9

24.7

0.36

346

(3017569) Oxygen content in Arterial blood

2.11

1.18

2.0

3.8

—

(40768800) Prostate Pathology biopsy report

130

0.46

1.16

1.5

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.50

1.15

1.4

1.0

nmol/l

0.3

0.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.69

1.14

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.69

1.14

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.69

1.14

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

225

1.43

1.12

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

234

1.42

1.11

1.2

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.39

1.09

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

144

1.54

1.09

1.4

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

261

1.39

1.08

1.5

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

659

1.24

1.08

1.4

1.5

—

(3022313) Gas panel - Capillary blood

409

1.31

1.07

2.9

3.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

237

1.40

1.05

1.7

e6/l

7112.4

11639.3

0.55

184

(1761482) Bacteria [#/volume] in Urine by Culture

216

0.60

1.04

2.4

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

420

1.30

1.04

2.0

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.67

1.04

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.67

1.04

1.0

—

(3022621) pH of Urine by Test strip

765

1.22

1.01

2.2

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

239

1.39

1.01

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.88

1.00

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.60

0.99

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.60

0.99

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

107

1.60

0.99

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.60

0.99

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.60

0.99

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.72

0.99

1.2

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.18

0.98

1.0

1.1

nmol/l

5.1

6.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

108

1.58

0.96

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.77

0.94

1.1

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.77

0.94

1.0

1.3

—

(3028433) Virus identified in Specimen by Culture

1.90

0.94

1.0

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

535

1.24

0.93

1.6

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.74

0.92

1.8

2.2

—

14.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.74

0.92

1.2

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

167

1.44

0.92

1.5

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.15

0.91

1.0

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.15

0.91

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

126

1.51

0.91

2.3

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

228

1.37

0.89

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

211

1.38

0.88

1.9

2.7

g/l

0.0

0.00

206

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.91

0.88

1.8

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.61

0.87

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

144

1.46

0.87

1.4

1.6

—

(1002224) Polysomnography panel

659

1.21

0.87

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

212

1.38

0.86

1.9

2.7

g/l

0.0

0.00

207

(3005988) Vibrio sp identified in Specimen by Organism specific culture

145

1.45

0.85

1.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

145

1.45

0.85

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.63

0.84

4.8

7.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.94

0.84

1.5

1.1

u/l

15.3

12.1

—

(3038026) Centromere Ab [Units/volume] in Serum

1.57

0.84

1.3

1.2

—

91.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

146

1.44

0.82

1.4

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

180

1.40

0.82

1.2

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

176

0.62

0.80

1.3

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

1.50

0.79

1.0

1.2

u/l

52.2

48.9

—

(40768793) Breast Pathology biopsy report

339

0.73

0.79

1.2

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

139

1.44

0.79

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.79

0.0

1.2

—

219.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.67

0.78

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.67

0.78

1.0

1.1

u/l

59.8

86.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.67

0.78

1.0

1.1

u/l

10.3

24.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.54

0.78

1.1

1.2

ratio

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

1.77

0.76

1.5

2.2

—

172.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

237

1.31

0.72

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.80

0.72

1.0

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.80

0.72

1.0

1.9

—

(3000012) Reticulocyte production index

1.75

0.71

1.0

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

239

0.71

0.69

3.6

3.8

54.8

55.9

0.15

239

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.85

0.68

33.8

6.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.85

0.68

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

110

1.46

0.68

1.2

1.0

—

(3011648) Oxygen content in Venous blood

1.60

0.68

3.8

1.9

11.6

0.01

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.68

1.0

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

127

1.42

0.68

1.5

1.7

49.8

56.1

0.20

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

1.33

0.68

2.5

2.6

—

(3004616) Nuclear Ab [Presence] in Serum

153

1.38

0.67

1.4

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

241

1.29

0.66

1.2

—

(3045424) Erythrocytes [Presence] in Urine

215

1.31

0.65

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.59

0.65

1.4

ug/l

7.2

8.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.73

0.64

1.2

1.1

—

(44790049)

146

1.37

0.64

1.5

—

(44806118)

146

1.37

0.64

1.5

—

(44790047)

146

1.37

0.64

1.5

—

(44790048)

146

1.37

0.64

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

270

1.27

0.62

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

233

0.73

0.61

3.3

3.5

e9/l

3.5

4.0

0.55

233

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

3.9

—

(40761536) Microorganisms panel - Urine sediment

120

1075

1.13

0.59

3.9

3.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

1.38

0.59

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

145

1316

1.11

0.58

4.0

3.8

31.9

31.8

0.04

114

959

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.43

0.56

1.4

1.5

nmol/l

1.6

1.5

0.20

(3038515) Glucose [Moles/volume] in Venous blood

160

0.69

0.55

1.8

2.8

mmol/l

6.1

7.1

0.58

155

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

107

1.41

0.55

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

123

0.65

0.54

1.3

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.48

0.53

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.54

0.53

1.7

1.5

u/l

13.7

13.1

—

(4094501)

287

1.22

0.51

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.50

0.51

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.47

0.50

1.7

2.2

u/field

3.2

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.52

0.48

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.49

0.47

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1.32

0.47

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.47

0.47

1.8

1.6

—

(3024263) Appearance of Synovial fluid

1.46

0.46

1.4

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

662

0.87

0.45

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.40

0.45

1.1

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.40

0.45

1.1

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

141

0.71

0.45

1.1

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.40

0.44

1.5

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

247

1.22

0.44

1.0

u/ml

1.5

2.0

0.53

128

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

163

0.73

0.43

1.1

1.2

u/l

27.8

29.6

0.04

137

(3000093) Morphology [Interpretation] in Blood Narrative

1.41

0.43

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.9

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.9

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.43

0.42

1.5

1.2

mmol/l

5.6

6.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.9

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.65

0.42

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.64

0.42

2.8

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.64

0.42

1.0

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.56

0.42

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1025

10079

1.05

0.41

3.6

3.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

1.3

—

(3011412) CD3 cells [#/volume] in Blood

123

1.30

0.40

2.1

2.7

e9/l

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

194

0.77

0.40

1.7

1.6

mmol/l

7.7

7.4

—

117

(40757373) Influenza virus identified in Isolate

0.00

0.40

0.0

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

2216670.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

623

0.88

0.40

1.7

2.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

260

1.20

0.39

1.6

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.34

0.39

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.43

0.39

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

1.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.35

0.38

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.33

0.37

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

271

1.18

0.37

1.1

1.0

u/ml

1.3

3.5

1.29

100

(3044941) Cell count panel - Synovial fluid

152

1.25

0.37

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

128

1190

1.08

0.35

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.63

0.35

1.8

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

1.25

0.35

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

108

1.30

0.35

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

414

1.14

0.35

1.7

1.6

iu/ml

0.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

108

998

1.09

0.35

2.9

2.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

109

1.29

0.33

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.31

0.33

2.7

3.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.31

0.33

1.7

1.4

—

5.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

132

1409

0.93

0.32

2.9

2.6

ug/l

0.5

0.7

5.19

820

(3035285) Chloride [Moles/volume] in Venous blood

0.73

0.31

1.0

2.3

mmol/l

106.3

105.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.73

0.31

1.0

2.3

mmol/l

4.1

4.0

—

(40768795) Lymph node Pathology biopsy report

102

1.28

0.30

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.23

0.29

1.9

1.4

g/l

42.7

33.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.23

0.29

1.1

1.5

—

(44813793)

1.28

0.28

1.3

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.28

0.28

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

149

1.21

0.28

1.2

1.7

—

(3012565) Volume of 24 hour Urine

1.27

0.27

1.0

2.7

2182.5

2018.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

119

0.75

0.27

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

172

0.81

0.27

1.7

2.7

mmol/l

1.6

1.4

0.56

164

(3051651) Icteric interference index of Serum or Plasma

1.21

0.26

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.21

0.26

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

1.27

0.26

2.7

2.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.70

0.26

5.6

6.7

—

40.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.69

0.26

1.0

1.1

miu/ml

1501.6

1640.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

879

0.93

0.24

2.5

4.3

ug/l

4.9

21.2

1.34

686

(3023430) Cat dander IgE Ab [Units/volume] in Serum

246

1.14

0.23

1.1

u/ml

2.8

5.0

0.84

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

285

2943

0.96

0.23

1.6

1.7

—

(3045788) Cell count panel - Pleural fluid

1.25

0.22

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.74

0.22

1.1

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

210

0.86

0.22

2.2

3.7

u/ml

28.4

26.6

0.07

205

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.19

0.21

1.6

2.0

—

144.8

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.7

—

282.9

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

2.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(4212803)

0.00

0.21

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

3.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

4.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

4.9

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

2.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.16

0.21

1.8

1.4

e6/l

32743.2

14451.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1.23

0.20

1.7

1.3

e6/l

2102.2

2216.7

—

(3034426) Prothrombin time (PT)

1.23

0.20

1.0

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

292

0.89

0.20

1.6

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

288

2805

1.03

0.18

2.2

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

128

1.17

0.18

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.21

0.18

1.0

—

(3017732) Neutrophils [#/volume] in Blood

884

1.06

0.17

3.2

2.5

e9/l

3.8

4.2

1.36

744

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.10

0.15

1.3

1.1

—

1.2

—

(21494434) Karyotype in Bone marrow

0.78

0.15

1.0

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.15

0.15

1.8

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

255

0.90

0.15

1.5

1.1

—

(4268621)

161

0.87

0.15

2.4

2.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

226

1.11

0.15

1.2

1.4

mmol/l

7.2

7.1

0.09

161

(3049717) Cytology report of Urine Cyto stain

284

1.09

0.15

2.0

2.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.10

0.15

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

1.16

0.14

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

316

0.92

0.14

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

382

1.08

0.14

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

233

0.90

0.14

3.9

3.0

mg/l

12.1

24.9

2.15

141

(3000330) Specific gravity of Urine by Test strip

490

1.06

0.13

1.9

2.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

232

0.90

0.13

2.0

2.3

ug/min

143.5

125.7

—

144

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

117

0.85

0.13

2.9

6.1

mg/l

9.8

10.5

—

109

(3019832) Treponema pallidum Ab [Presence] in Serum

219

2242

0.97

0.13

1.6

1.7

—

(3037121) Protein [Mass/volume] in Urine

375

0.93

0.12

2.1

3.7

g/l

0.1

0.3

3.05

163

(3044640) Blood type and Crossmatch panel - Blood

380

3742

1.02

0.12

2.2

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

271

0.92

0.11

1.9

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

157

0.89

0.11

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

289

1.07

0.11

2.7

2.2

umol/l

5.3

4.8

0.14

207

(3000492) Spirometry study

142

1385

1.03

0.10

1.3

—

(3042631) Mycobacterium sp identified in Specimen

106

1.13

0.09

4.6

2.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.79

0.08

1.2

3.2

u/ml

477.4

739.8

—

(4034850)

389

0.95

0.08

7.4

7.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.04

0.08

1.0

—

4.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.07

0.07

4.1

3.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

112

0.89

0.07

2.1

3.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.06

0.07

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

183

0.93

0.06

1.4

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

305

1.05

0.06

1.1

u/ml

1.0

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

315

0.95

0.06

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

178

1.07

0.05

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

247

1.05

0.05

6.2

6.1

iu/ml

502.0

196.9

—

(40768441) Liver Pathology biopsy report

1.11

0.05

2.4

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

100

1.10

0.05

2.2

2.5

e6/l

894.7

796.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

323

0.96

0.05

1.2

1.1

u/ml

4.0

5.2

0.34

171

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

0.94

0.04

3.9

3.1

—

1647.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

109

0.92

0.04

1.2

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

350

0.97

0.03

1.2

1.1

u/ml

0.9

1.6

0.53

135

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

241

1.04

0.02

1.3

1.2

u/ml

1.5

4.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

228

0.96

0.02

1.2

—

(3045142) Bone marrow Pathology biopsy report

113

1.06

0.02

1.1

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

217

0.97

0.01

1.5

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

106

0.94

0.01

4.4

3.8

u/ml

20.7

51.8

—

106

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

234

1.03

0.00

1.3

u/ml

2.2

4.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

236

0.97

0.00

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

126

1.03

0.00

1.9

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

196

1.02

0.00

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

306

1.01

0.00

1.2

1.1

u/ml

0.1

1.2

—

122

(3025130) Human papilloma virus identified in Specimen

258

1.01

0.00

1.7

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

113

0.97

0.00

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

323

0.99

0.00

2.0

3.5

u/ml

15.8

809.9

0.99

277

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

3.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.00

0.00

2.8

2.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(4024509)

0.93

0.00

1.7

1.4

—

(3036603) Volume of Urine

1.01

0.00

1.6

—

2101.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.00

0.00

1.0

1.1

—

(4211845)

0.86

0.00

3.0

2.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

2.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

3.8

—

14.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

4.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

4.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

1.00

0.00

3.0

2.6

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

100

1.00

0.00

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(40768446) Kidney Pathology biopsy report

0.98

0.00

1.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.98

0.00

1.7

2.2

ug/l

16.6

151.4

—

(4038314)

0.00

0.0

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.4

—

423.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.8

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.02

0.00

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.3

1.8

—

(4146454)

0.98

0.00

2.3

2.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_ANAPER and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_ANAPER	1.316 [1.11, 1.56]	0.002
Birth year	0.996 [0.99, 1.0]	0.366

During the follow-up period (1.1.1998 — 31.12.2019), 180 out of 4742 females with F5_ANAPER died.

Males

Parameter	HR [95% CI]	p-value
F5_ANAPER	1.272 [1.09, 1.48]	0.002
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 252 out of 2802 males with F5_ANAPER died.

Mortality risk

Mortality risk for people of age

years, who have F5_ANAPER.

N-year risk	Females	Males
1	0.129%	0.232%
5	0.797%	1.426%
10	1.82%	3.432%
15	3.895%	6.322%
20	6.79%	10.838%

Relationships between endpoints

↥

Index endpoint: F5_ANAPER – Anankastic personality disorder

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Anankastic personality disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints